

Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|18|4|390-399
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.18, Iss.4, 2018-04, pp. : 390-399
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




A Wnt-ow of Opportunity: Targeting the Wnt/&bgr;-Catenin Pathway in Breast Cancer
Current Drug Targets, Vol. 11, Iss. 9, 2010-09 ,pp. :






Targeting TGF-β signaling in cancer
By Katz Lior H
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. :